Deuruxolitinib showed significant efficacy and safety in hair regrowth stimulation among adult patients with alopecia areata, ...

Now, writing in Nature, Nordmann et al. report that JAK inhibition reduces disease severity and promotes recovery in mouse models and individuals with TEN. TEN is characterized by apoptotic ...

The landscape of atopic dermatitis (AD) treatment is advancing with approvals of oral and topical Janus kinase (JAK) ...

Andrew Rosenberg, DVM, DACVD, provided an overview of Janus kinase inhibitors for treating canine atopic dermatitis ...

Alumis is advancing ESK-001 for plaque psoriasis with phase 3 data expected in 2026. Read why ALMS stock is compelling yet ...

When the session moderator asked whether the findings meant cardiovascular risk was no longer a worry with JAK inhibitors ...

JAK inhibitors are a class of medications that work by blocking Janus kinases (JAKs), enzymes that are involved in the signaling pathways of various cytokines and growth factors. JAK inhibitors offer ...

The following is a summary of “Comparative safety of oral Janus kinase inhibitors versus dupilumab in patients with atopic ...

Patients with IBD don’t face an increased risk for major adverse cardiovascular events when taking Janus kinase inhibitors ...

A rare and potentially fatal skin infection with nightmarish outcomes may soon have a cure.

The use of rituximab, abatacept and Janus kinase inhibitors (JAKis) in individuals with rheumatoid arthritis (RA) was ...

TEN is a rare disease that affects one to two million people worldwide every year. It has an extremely unpredictable onset ...